Das Oncocare Private Limited, a active private limited company, was established on 12 September 2018 in Goregaon E Mumbai, Maharashtra, India. Engaging in drug formulation & development within the hospital and medical care sector, it holds CIN: U74999MH2018PTC313929. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Its leadership includes Bandita Saisudha Patro (Director), Kiran Das (Director), Jasmine Das (Director). Past directors included Netajee Patro. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at 1St Floor, Commerz Ii, Cts No 95 4 B 3 & 4 590 Oberoi Garden City, Off Western Express, Highway,, Goregaon E Mumbai, Maharashtra, 400063.
U74999MH2018PTC313929
313929
12 September 2018
₹1.00 M
₹1.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Das Oncocare Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bandita Saisudha Patro | Director | 12 Sep 2018 | Current |
| Kiran Das | Director | 12 Sep 2018 | Current |
| Jasmine Das | Director | 12 Sep 2018 | Current |
| Netajee Patro | Director | 22 Jul 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Das Oncocare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 11.07% increase. The company also saw a substantial fall in profitability, with a 15.7% decrease in profit. The company's net worth observed a substantial decline by a decrease of 83.98%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Das Oncocare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Das Oncocare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Das Oncocare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Das Oncocare's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Das Oncocare Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was completed.
The activity Netajee Patro was appointed as a Director was appointed as a Director on 22 Jul 2022 & has been associated with this company since 3 years 5 months . was completed.
Progress on Das Oncocare Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Mumbai. was documented.
The activity Bandita Saisudha Patro was appointed as a Director was appointed as a Director on 12 Sep 2018 & has been associated with this company since 7 years 3 months . was completed.
Progress on Kiran Das was appointed as a Director was appointed as a Director on 12 Sep 2018 & has been associated with this company since 7 years 3 months . was documented.
The activity Jasmine Das was appointed as a Director was appointed as a Director on 12 Sep 2018 & has been associated with this company since 7 years 3 months . was completed.
The CIN of Das Oncocare Private Limited is U74999MH2018PTC313929.
Das Oncocare Private Limited is headquartered at 1St Floor, Commerz Ii, Cts No 95 4 B 3 & 4 590 Oberoi Garden City, Off Western Express, Highway,, Goregaon E Mumbai, Maharashtra, 400063.
Das Oncocare Private Limited was incorporated on 12 September 2018.
The current directors of Das Oncocare Private Limited are
The primary industry of Das Oncocare Private Limited is Hospital And Medical Care.
Das Oncocare Private Limited is unlisted.
The authorized capital of Das Oncocare Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX